HQ Visit Reinforces Inflection Point At Hand

Loading...
Loading...
According to Goldman Sachs, a recent visit to Monsanto Co.
MON
headquarters was positive while meeting with commercial, financial, and technology functions. Currently a "buy" stock, the shares are expected to reach $65 over the next 12 months. Monsanto is back on the offensive after the challenging launches of SmartStax and RR2, expecting to be met with investor criticism. Accumulation of shares is advised, due to the strongly favored upside for investors based on the risk/reward setup. Current stock price is $57.61.
Posted In: Analyst ColorAnalyst RatingsTrading IdeascornFertilizers & Agricultural ChemicalsGoldman SachsMaterialsMonsantoRR2Seeds & TraitsSmartStaxsoybean
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...